PharmGen Science, Inc.

KOSE:A004720 Voorraadrapport

Marktkapitalisatie: ₩89.2b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

PharmGen Science Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Lee Seung-Yeol

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

PharmGen Science, Inc.'s (KRX:004720) Share Price Could Signal Some Risk

Aug 12
PharmGen Science, Inc.'s (KRX:004720) Share Price Could Signal Some Risk

PharmGen Science's (KRX:004720) Shareholders Have More To Worry About Than Only Soft Earnings

Mar 27
PharmGen Science's (KRX:004720) Shareholders Have More To Worry About Than Only Soft Earnings

Is Wooridul Pharmaceutical (KRX:004720) A Risky Investment?

Mar 21
Is Wooridul Pharmaceutical (KRX:004720) A Risky Investment?

Investors Who Bought Wooridul Pharmaceutical (KRX:004720) Shares Five Years Ago Are Now Up 55%

Jan 19
Investors Who Bought Wooridul Pharmaceutical (KRX:004720) Shares Five Years Ago Are Now Up 55%

Does The Market Have A Low Tolerance For Wooridul Pharmaceutical Limited's (KRX:004720) Mixed Fundamentals?

Dec 21
Does The Market Have A Low Tolerance For Wooridul Pharmaceutical Limited's (KRX:004720) Mixed Fundamentals?

Are Wooridul Pharmaceutical's (KRX:004720) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 25
Are Wooridul Pharmaceutical's (KRX:004720) Statutory Earnings A Good Reflection Of Its Earnings Potential?

CEO

Lee Seung-Yeol (44 yo)

no data

Tenure

Seung-Yeol Lee serves as the Chief Executive Officer of PharmGen Science Inc. (formerly known as Wooridul Pharmaceutical Limited). Seung-Yeol Lee serves as the President of Winnova Co., Ltd. Seung-Yeol Lee...